Check out the companies making headlines before the bell: CarMax — Shares jumped 10% after CarMax reported first-quarter results that exceeded analysts' expectations. The car retailer earned $1.38 per share on revenue of $7.55 billion. Analysts polled by LSEG expected a profit of $1.16 per share on revenue of $7.52 billion. GMS — The specialty building products stock jumped 26% as a bidding war for GMS has reportedly developed between QXO and Home Depot . QXO said late Wednesday that it was offering $95.20 per share for QXO, while The Wall Street Journal reported Friday that Home Depot had also made an offer privately. Shares of QXO were up 2.4% in premarket trading, while Home Depot dipped less than 1%. Darden Restaurants — Shares were up nearly 3% after the Olive Garden parent's fourth-quarter results beat on both the top and bottom lines. Adjusted earnings were $2.98 a share, topping expectations by 1 cent, according to LSEG. Revenue was $3.27 billion, versus the $3.26 billion expected. Darden also authorized a new $1 billion share repurchase program. Jack in the Box — The fast-food stock shed 1% after a Stifel downgrade to hold from buy. The firm said the Trump's administration's immigration policies are a headwind for Jack in the Box . Accenture — Shares fell 3.7% after the IT company reported a 6% drop in new bookings in U.S. currency in its fiscal third quarter to $17.73 billion. Overall, however, Accenture topped expectations, posting earnings of $3.49 per share on revenue of $17.73 billion. Analysts polled by LSEG had expected earnings per share of $3.32 on revenue of $17.30 billion. Circle — Shares of Circle continued to climb on Friday as investors cheered the Senate approval of its proposed stablecoin legislation , the GENIUS Act. The stock was up 14% in premarket trading, after the bill passed the Senate on Tuesday. On Wednesday, it rose 33%. Kroger — The supermarket chain fell less than 1% ahead of its first-quarter results. Analysts polled by LSEG are anticipating earnings of $1.46 per share on revenue of $45.19 billion. Regencell Bioscience — Shares dropped more than 17%, continuing Regencell's volatile moves this week after a 38-for-1 split took effect. It jumped more than 280% on Monday and 30% on Tuesday before falling more than 18% Wednesday. — CNBC's Michelle Fox, Tanaya Macheel and Jesse Pound contributed reporting.
